{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:59:28Z","timestamp":1784357968605,"version":"3.55.0"},"reference-count":76,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Statutory Activities by the Polish Ministry of Science and Higher Education","award":["SUBK.C120.23.013"],"award-info":[{"award-number":["SUBK.C120.23.013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objectives: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder with diverse pathogenetic mechanisms and clinical manifestations. Phenotype D PCOS is characterized by oligomenorrhoea and polycystic ovaries without hyperandrogenism. Altered adipokine profiles may contribute to reproductive and metabolic disturbances. Chemerin is an adipokine involved in inflammatory and metabolic processes. It remains unclear whether altered chemerin levels in PCOS reflect metabolic dysfunction alone or are directly associated with hyperandrogenism. The aim of this study was to compare serum chemerin levels in women with normoandrogenic PCOS and a control group. Methods: This cross-sectional preliminary study included 49 women with phenotype D PCOS and 40 healthy, age- and body mass index (BMI)-matched controls. Anthropometric, biochemical, hormonal parameters, and serum chemerin concentrations were assessed. Results: Serum chemerin concentrations did not differ significantly between the groups. In the PCOS group, the 95% confidence interval ranged from 198.61 to 234.37, while in the controls, it ranged from 187.13 to 216.21. In women with PCOS, chemerin showed significant positive correlations with weight, BMI, waist and hip circumference, total adipose tissue, and both gynoid and android fat content. Positive correlations were also observed with highly sensitive C-reactive protein (hs-CRP), insulin, glucose, triglycerides, and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), and a negative correlation was found with high-density lipoprotein (HDL) cholesterol. Chemerin was weakly negatively correlated with sex hormone binding globulin (SHBG) and positively correlated with the free androgen index (FAI). In the control group, chemerin correlated positively with CRP, insulin, triglycerides, total and gynoid adipose tissue, and negatively correlated with HDL cholesterol and SHBG. Conclusions Although chemerin levels did not differ from controls, chemerin was associated with metabolic and inflammatory markers in both groups. These findings should be considered preliminary due to the limited sample size. Chemerin may reflect metabolic and inflammatory status rather than hyperandrogenism in normoandrogenic PCOS.<\/jats:p>","DOI":"10.3390\/jcm15020772","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:36:33Z","timestamp":1768898193000},"page":"772","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum Chemerin Levels in Polish Women with PCOS-Phenotype D"],"prefix":"10.3390","volume":"15","author":[{"given":"Justyna","family":"Kuliczkowska-P\u0142aksej","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Internal Diseases, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jowita","family":"Halupczok-\u017by\u0142a","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Patology, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4942-9954","authenticated-orcid":false,"given":"\u0141ukasz","family":"Gojny","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Diseases, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zembska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Diseases, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Zimoch","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Diseases, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Skrzypiec-Spring","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-6596","authenticated-orcid":false,"given":"Marek","family":"Bolanowski","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Diseases, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Jawiarczyk-Przyby\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Diseases, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod., 19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MED.0b013e32835a000e","article-title":"Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome","volume":"19","author":"Huang","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/humrep\/den263","article-title":"Cardiometabolic risk in polycystic ovary syndrome: A comparison of different approaches to defining the metabolic syndrome","volume":"23","author":"Cussons","year":"2008","journal-title":"Hum. Reprod."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coemr.2020.03.004","article-title":"Polycystic ovary syndrome phenotypes and prevalence: Differential impact of diagnostic criteria and clinical versus unselected population","volume":"12","author":"Mumusoglu","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00404-024-07408-2","article-title":"PCOS phenotype focus: Phenotype D under the magnifying glass","volume":"309","author":"Myers","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"232454","DOI":"10.1155\/2014\/232454","article-title":"Adipokines and the female reproductive tract","volume":"2014","author":"Reverchon","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin is a novel adipokine associated with obesity and metabolic syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12020-012-9698-8","article-title":"Chemerin: A potential endocrine link between obesity and type 2 diabetes","volume":"42","author":"Roman","year":"2012","journal-title":"Endocrine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1210\/en.2012-1424","article-title":"Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovary syndrome","volume":"153","author":"Wang","year":"2012","journal-title":"Endocrinology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1096\/fj.201802829R","article-title":"Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients","volume":"33","author":"Li","year":"2019","journal-title":"FASEB J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/des089","article-title":"Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells","volume":"27","author":"Reverchon","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/biolre\/ioy096","article-title":"Polycystic ovary syndrome: Possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes\/macrophages","volume":"99","author":"Lima","year":"2018","journal-title":"Biol. Reprod."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/09513590.2015.1075501","article-title":"Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?","volume":"32","author":"Yang","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/09513590.2018.1462316","article-title":"Serum chemerin level in women with PCOS and its relation with the risk of spontaneous abortion","volume":"34","author":"Yang","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/09513590.2014.968547","article-title":"Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome","volume":"31","author":"Kort","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.dsx.2019.01.050","article-title":"Serum chemerin levels in polycystic ovary syndrome after metformin therapy","volume":"13","author":"Foda","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yu, M., Yang, Y., Huang, C., Ge, L., Xue, L., Xiao, Z., Xiao, T., Zhao, H., Ren, P., and Zhang, J.V. (2022). Chemerin: A functional adipokine in reproductive health and diseases. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081910"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Palomba, S., Seminara, G., Costanzi, F., Caserta, D., and Aversa, A. (2024). Chemerin and polycystic ovary syndrome: A comprehensive review of its role as a biomarker and therapeutic target. Biomedicines, 12.","DOI":"10.3390\/biomedicines12122859"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chen, P., Jia, R., Liu, Y., Cao, M., Zhou, L., and Zhao, Z. (2022). Progress of adipokines in the female reproductive system: A Focus on polycystic ovary syndrome. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.881684"},{"key":"ref_22","first-page":"174","article-title":"International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) nomenaclature, pharmacology, and function","volume":"70","author":"Kennedy","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Unfer, V., Dinicola, S., and Russo, M. (2023). A PCOS paradox: Does inositol therapy find a rationale in all the different phenotypes?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076213"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","article-title":"Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes","volume":"94","author":"Guastella","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/09513590.2019.1613640","article-title":"Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes\u2014A cross-sectional study","volume":"35","author":"Gupta","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00404-015-3889-5","article-title":"Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria","volume":"293","author":"Jamil","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/humrep\/der418","article-title":"Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: A prospective study","volume":"27","author":"Panidis","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/09513590.2015.1107895","article-title":"Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes","volume":"32","author":"Zhao","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejogrb.2018.02.031","article-title":"Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes","volume":"224","author":"Tripathy","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/humrep\/deaa190","article-title":"Outcome of in-vitro oocyte maturation in patients with PCOS: Does phenotype have an impact?","volume":"35","author":"Mackens","year":"2020","journal-title":"Hum. Reprod."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A 20-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Dadachanji, R., Patil, A., Joshi, B., and Mukherjee, S. (2021). Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0246862"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/clinem\/dgad356","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"109","author":"Bril","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/obr.12009","article-title":"Towards an integrative approach to understanding the role of chemerin in human health and disease","volume":"14","author":"Rourke","year":"2013","journal-title":"Obes. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"28175","DOI":"10.1074\/jbc.M700793200","article-title":"Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism","volume":"282","author":"Goralski","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"111504","DOI":"10.1016\/j.mce.2021.111504","article-title":"Role of Chemerin in the Control of Glucose Homeostasis","volume":"541","author":"Leniz","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_41","first-page":"32","article-title":"Higher Levels of Circulating Chemerin in Obese Women with Gestational Diabetes Mellitus","volume":"11","author":"Ademoglu","year":"2015","journal-title":"Acta Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1210\/jc.2008-1833","article-title":"Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population","volume":"94","author":"Bozaoglu","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","first-page":"191","article-title":"The Adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers","volume":"25","author":"Bakkar","year":"2018","journal-title":"Egypt. J. Immunol."},{"key":"ref_44","first-page":"1296","article-title":"Relationship of Serum Novel Adipokine Chemerin Levels with Body Composition, Insulin Resistance, Dyslipidemia and Diabesity in Saudi Women","volume":"21","author":"Habib","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_45","first-page":"235","article-title":"Relationship of serum Chemerin to obesity and type 2 diabetes mellitus","volume":"89","author":"Wang","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2169\/internalmedicine.50.5025","article-title":"Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome","volume":"50","author":"Dong","year":"2011","journal-title":"Intern. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/cen.12707","article-title":"Chemerin and prediction of Diabetes mellitus type 2","volume":"82","author":"Bobbert","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41366-018-0157-3","article-title":"Link between Chemerin, Central Obesity, and Parameters of the Metabolic Syndrome: Findings from a Longitudinal Study in Obese Children Participating in a Lifestyle Intervention","volume":"42","author":"Niklowitz","year":"2018","journal-title":"Int. J. Obes."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Pelczynska, M., Miller-Kasprzak, E., Piatkowski, M., Mazurek, R., Klause MSuchecka, A., Bucon, M., and Bogdanski, P. (2023). The Role of Adipokines and Myokines in the Pathogenesis of Different Obesity Phenotypes\u2014New Perspectives. Antioxidants, 12.","DOI":"10.3390\/antiox12122046"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/cen.12249","article-title":"Effect of Lifestyle Modification on Serum Chemerin Concentration and Its Association with Insulin Sensitivity in Overweight and Obese Adults with Type 2 Diabetes","volume":"80","author":"Kim","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.metabol.2011.10.008","article-title":"Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity","volume":"61","author":"Chakaroun","year":"2012","journal-title":"Metabolism"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1515\/jpem-2017-0431","article-title":"Decrease in serum chemerin through aerobic exercise plus dieting and its association with mitigation of cardio-metabolic risk in obese female adolescents","volume":"31","author":"Liu","year":"2018","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Yilmaz, D.T., Gul, M.A., Capraz, M., Demir, H.D., and Tekcan, A. (2025). Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers. Biomedicines, 13.","DOI":"10.3390\/biomedicines13112619"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Mukherji, A.B., Idowu, V., Zhao, L., Leung, L.L.K., Shen, S., Palaniappan, L., and Morser, J. (2024). Chemerin Levels in Individuals with Type 2 Diabetes and a NormalWeight versus Individuals with Type 2 Diabetes and Obesity: An Observational, Cross-Sectional Study. Biomedicines, 12.","DOI":"10.3390\/biomedicines12050983"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cca.2015.09.015","article-title":"Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume","volume":"23","author":"Huang","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/jcmm.12282","article-title":"Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients","volume":"18","author":"Fulop","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cen.12363","article-title":"Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects","volume":"81","author":"Lorincz","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I","article-title":"Chem23, as putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some promary HIV-1 strains","volume":"28","author":"Samson","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.4049\/jimmunol.0903378","article-title":"Chemerin peptides promote phagocytosis in a ChemR23-and Syk-dependent manner","volume":"184","author":"Cash","year":"2010","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20030382","article-title":"Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids","volume":"198","author":"Wittamer","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"103628","DOI":"10.1016\/j.jri.2022.103628","article-title":"Systemic and ovarian inflammation in women with polycystic ovary syndrome","volume":"151","author":"Zhai","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13048-025-01621-6","article-title":"Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation","volume":"18","author":"Su","year":"2025","journal-title":"J. Ovarian Res."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Chen, H., Zhang, Y., Li, S., Tao, Y., Gao, R., Xu, W., Yang, Y., Cheng, K., Wang, Y., and Qin, L. (2021). The association between genetically predicted systemic inflammatory regulators and polycystic ovary syndrome: A Mendelian randomization study. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.731569"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13679-014-0124-9","article-title":"Low-grade inflammation, obesity, and diabetes","volume":"3","author":"Pereira","year":"2014","journal-title":"Curr. Obes. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/09513590.2020.1769061","article-title":"Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome","volume":"36","author":"Abruzzese","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e00307","DOI":"10.1002\/edm2.307","article-title":"Serum and follicular fluid chemerin and chemerin mRNA expression in women with polycystic ovary syndrome: Systematic review and meta-analysis","volume":"5","author":"Mansoori","year":"2022","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1007\/s43032-021-00709-w","article-title":"Blood circulating levels of adipokines in polycystic ovary syndrome patients: A systematic review and meta-analysis","volume":"28","author":"Mehrabani","year":"2021","journal-title":"Reprod. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/09513590.2014.888412","article-title":"Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome","volume":"30","author":"Guzel","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.47391\/JPMA-BAGH-16-15","article-title":"Simultaneous determination and association between serum levels of irisin and chemerin in PCOS","volume":"74","author":"Abdullateef","year":"2024","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Niepsuj, J., Piwowar, A., Franik, G., and Bizo\u0144, A. (2024). Impact of smoking and obesity on the selected peptide hormones and metabolic parameters in the blood of women with polycystic ovary syndrome\u2014preliminary study. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168713"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Martinez-Garcia, M.A., Moncayo, S., Insenser, M., Alvarez-Blasco, F., Luque-Ramirez, M., and Escobar-Morreale, H.F. (2019). Metabolic cytokines at fasting and during macronutrient challenges: Influence of obesity, female androgen excess, and sex. Nutrients, 11.","DOI":"10.3390\/nu11112566"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"023","DOI":"10.1210\/jendso\/bvae023","article-title":"Serum chemerin levels correlate with severity of dysglycemia in young adult women with polycystic ovary syndrome","volume":"8","author":"Bose","year":"2024","journal-title":"J. Endocr. Soc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0300060516645421","article-title":"Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome","volume":"44","author":"Guvenc","year":"2016","journal-title":"J. Int. Med. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3109\/09513590.2014.928687","article-title":"Elevated serum chemerin in Chinese women with hyperandrogenic PCOS","volume":"30","author":"Wang","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12958-022-00959-6","article-title":"High androgen concentrations in follicular fluid of polycystic ovary syndrome women","volume":"20","author":"Bongrani","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Vuong, A.D.B., Tran, N.H., Pham, T.H., Le, H.A.M., and Nguyen, P.N. (2025). Soluble fibrin monomer complex and D-dimer concentration between patients at low and high risk of venous thromboembolism before delivery according to RCOG Score Assessment: An observational study among 100 third-trimester Vietnamese pregnancies. J. Clin. Med., 14.","DOI":"10.3390\/jcm14051399"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/772\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:57:22Z","timestamp":1768899442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":76,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15020772"],"URL":"https:\/\/doi.org\/10.3390\/jcm15020772","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]}}}